Ensuring Safety in Gene-Edited iPSC Therapies to Accelerate Development of Next-Generation Treatments

Time: 12:30 pm
day: Day Two Track A AM


  • Focusing on methods for maintaining genomic stability and minimizing mosaicism after gene editing in iPSCs, promoting safety
  • Developing new genomic stability testing methods to ensure the safety of iPSC-derived cell therapies